This issue marks a new era for this publication as it is the first to be published under the NASPCC umbrella. We anticipate that this will allow us to reach a much larger audience.

 As an old hand … more

This month we’re talking about” “imaging for prostate cancer.” “Imaging technology is advancing” “rapidly and is transforming” “both prostate cancer diagnosis” “and offering new insight into” “how … more

For men just diagnosed with prostate cancer, the threat treatment poses for sexual function looms large and can play a major role in which treatment they choose. It can even lead some men to choose … more

Many patients fear chemotherapy not only because of its side effects but also because of what the need for chemotherapy implies about their prognosis. Fortunately, each physician we spoke with this … more

This issue is devoted to the genetics and genomics of prostate cancer, which is one of the most promising and exciting areas of prostate cancer research. Already, this line of investigation is having … more

In June, we’re talking about ways in which you as a patient can benefit from and in turn contribute to the prostate cancer community. 

What do we mean by that? Chances are, when you were first told … more

In May, we’re talking about clinical trials for prostate cancer patients. We also have an ulterior motive: we would love it, if after reading this issue, each and every one of you asks your doctor if … more

This issue is devoted to focal therapies. Interest in focal therapy is fueled by the promise of cancer control with fewer side effects than are seen after radiation or radical prostatectomy. From the … more